Endurant Evo US Clinical Trial

A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 139 participants.

Also called NCT02393716

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 139 participants (enrolled count) (from the registry)
Sponsor
  • Medtronic Registry lists this organization as the lead sponsor
Registry
  • NCT NCT02393716
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Terminated (from the registry)

Technical summary

Registry record NCT02393716. Allocation not applicable; no masking; primary purpose treatment. Start 2015-04 (actual); primary completion 2021-06-25 (actual). Results posted on 2022-12-06.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Endurant Evo US Clinical Trial
Condition
Abdominal Aortic Aneurysm
Condition
AAA
Intervention (Device)
Endurant Evo AAA Stent Graft System
Intervention (Procedure)
Endovascular aneurysm repair (EVAR)
Lead sponsor
Medtronic Cardiovascular (class: industry)

Record details

Record id
cardio:ct-nct02393716
Content hash
cdaaf2d8d140a8a86631762b66ce6639c790fc9161b49e6979ee09a81aeecaf9